December 13th, Webinar | December 15th, 2022, Offline Summit, Shanghai, China,
In recent years, with the increasing emphasis on scientific and technological innovation in China, the continuous advancement of supporting medical reform policies, and the impact of the pandemic, the living environment of pharmaceutical enterprises and medical device companies has quietly changed. With the rise of technologies such as 5G, Internet of Things, AI, and big data, the ecological operation efficiency of pharmaceutical enterprises has been greatly improved, thereby improving the overall innovation capability of the industry. The digital development has gone through multiple stages, gradually realizing the accumulation, efficiency improvement and exponential growth of the industry. However, at the same time, the enterprises still face internal and external resistance in the process of digital layout. How to further strengthen the construction of digital pharma, improve the level of intelligent manufacturing, and realize the digital transformation of the entire industry chain of pharmaceutical R&D, production, compliance, marketing and circulation, are still their goals.